UBS raised the firm’s price target on Oracle (ORCL) to $225 from $200 and keeps a Buy rating on the shares. While the tough macro has dented other software firms’ results, Oracle posted a growth acceleration to 11%, strong license growth of 8%, and raised its FY26 growth guidance, the analyst tells investors in a research note. The firm believes the FY25 revenue guidance raise will outweigh the likelihood that FY26 margins will erode, and thinks the after-hours rally will get bought.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL: